Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy

ClinicalTrials.gov ID: NCT06346340

Public ClinicalTrials.gov record NCT06346340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 10:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy

Study identification

NCT ID
NCT06346340
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bausch & Lomb Incorporated
Industry
Enrollment
97 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2024 (Actual)
Primary completion
Feb 24, 2025 (Actual)
Completion
Feb 24, 2025 (Actual)
Last update posted
Jul 6, 2026

2024 – 2025

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Site 105 Laguna Hills California 92655 —
Site 102 Petaluma California 92954 —
Site 109 Sacramento California 94206 —
Site 111 Grand Junction Colorado 81501 —
Site 103 Largo Florida 33770 —
Site 106 Oak Lawn Illinois 60453 —
Site 108 Alexandria Minnesota 56308 —
Site 104 St Louis Missouri 63131 —
Site 101 Somersworth New Hampshire 03878 —
Site 107 Sioux Falls South Dakota 57108 —
Site 110 San Antonio Texas 78229 —
Site 112 San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06346340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06346340 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →